Two Epstein-Barr virus (EBV)–based testing approaches have shown promise for early detection of nasopharyngeal carcinoma (NPC). Neither has been independently validated nor their performance compared.

Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis® LCS. Established U.S. commercial and clinical infrastructure combined with Medicare reimbursem ...

Researchers have found that digital breast tomosynthesis (DBT) has improved breast cancer screening performance in community practice and identifies more invasive cancers, compared to digital ...

The US Food and Drug Administration (FDA) has granted marketing clearance to Eyonis LCS, an artificial intelligence-powered ...

Colorectal cancer is the second leading cause of cancer-related deaths for males and females. Screening for colorectal cancer is an effective strategy to reduce morbidity and mortality. The ...

Oran Muduroglu, proven medical imaging entrepreneur, to lead U.S. launch of eyonis LCS Established U.S. commercial and clinical infrastructure combined with Medicare reimbursement pathway ...

Colorectal cancer (CRC) is the second-leading cause of cancer death in the US, but it does not have to be. Prevention and early intervention can save lives. Screening prevents CRC by finding and ...

Oops, they did it again — that is, the U.S. Preventive Services Task Force once more changed their screening recommendations for breast cancer. In 2016, the USPSTF ...

Adamson is a dermatologist and health disparities researcher at Dell Medical School. Patel is a resident physician at Brigham and Women’s Hospital in Boston. Welch is a general internist at Brigham ...